Amerika Serikat - Inggris - NLM (National Library of Medicine)

greencos co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - purpose: antiseptic uses hand sanitizer to help reduce bacteria that potentially can cause disease.

Amerika Serikat - Inggris - NLM (National Library of Medicine)

handy labs - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antiseptic hand sanitizer to help reduce bacteria that potentially can cause disease.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

edwards lifesciences pty ltd - 60350 - aortic heart valve bioprosthesis/synthetic polymer aorta graft - the device is a pre-assembled, ready-to-implant bioprosthetic valved conduit with resilia tissue, designed to be used in bio-bentall procedures. the device is a stented trileaflet valve pre-assembled to a woven polyester graft impregnated with gelatin. the device is stored in a dry packaging condition and supplied sterile. intended for use as a replacement for the aortic heart valve and the ascending aorta. is indicated for patients who require replacement of their native or prosthetic aortic valve, and the associated repair or replacement of a damaged or diseased ascending aorta.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 60242 - aortic heart valve bioprosthesis - the bioprostheses consist of porcine valve that has been secured to the cloth covered stent. the aortic valve sewing ring is scalloped to enable mounting within the annulus or in the supra-annular position. the stent is fitted with metal post markers to allow radiographic visualisation and are placed close to the apex of each stent post to allow visualization of the relationship of the stent posts to each other and to the aortic or ventricular wall. intended for the replacement of pathological or prosthetic aortic valves.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 60244 - mitral heart valve bioprosthesis - the bioprostheses consist of porcine valve that has been secured to the cloth covered stent. the mitral valve sewing ring contains polyester felt, allowing for easy needle penetration and low suture drag. the stent is fitted with metal post markers to allow radiographic visualisation. the markers are placed close to the apex of each stent post to allow visualization of the relationship of the stent posts to each other and to the aortic or ventricular wall. indicated for the replacement of pathological or prosthetic mitral valves.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

abbott medical australia pty ltd - 60242 - aortic heart valve bioprosthesis - the sjm epic supra heart valve is a triple-composite bioprosthetic heart valve manufactured from select porcine aortic valve cusps. the sjm epic supra valve is intended as a replacement for a diseased or malformed native aortic heart valve. it may also be used as a replacement for a previously implanted aortic prosthetic heart valve.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

abbott medical australia pty ltd - 60244 - mitral heart valve bioprosthesis - the sjm epic mitral valve is a triple-composite bioprosthetic heart valve manufactured from select porcine aortic valve cusps. the sjm epic mitral valve is intended as a replacement for a diseased, damaged or malformed mitral native heart valve. it may also be used as a replacement for a previously implanted mitral prosthetic heart valve.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

medtronic australasia pty ltd - 60242 - aortic heart valve bioprosthesis - the valved conduit consist of porcine valve fitted into woven polyester conduit. an external radiopaque reinforcing ring is located at the level of the valve annulus to prevent loss of leaflet coaptation. model 150 is a valved conduit with a modified orifice. the proximal and distal ends of the conduit are constructed of 10 cm (relaxed length) woven conduit grafts anastomosed to the short centre section containing the bioprosthetic valve. this device is mr conditional. indicated for use in reconstructive procedures for the repair of congenital or acquired cardiac and great vessel malformations or pathology.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

edwards lifesciences pty ltd - 60242 - aortic heart valve bioprosthesis - the carpentier-edwards perimount pericardial aortic bioprosthesis is intended for use in patients whose aortic valvular disease is sufficiently advanced to warrant replacement of their natural valve with a prosthetic one. it is also intended for use in patients with a previously implanted aortic valve prosthesis that is no longer functioning adequately and requires replacement. in the latter case, the previously implanted prosthesis is surgically excised and replaced by the replacement prosthesis.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

edwards lifesciences pty ltd - 66209 - valve-non-specific transcatheter heart valve bioprosthesis - the edwards sapien 3 transcatheter heart valve (thv) is comprised of a balloon-expandable, radiopaque, cobalt-chromium alloy frame, a trileaflet bovine pericardial tissue valve, a polyethylene terephthalate (pet) inner skirt, and a pet outer skirt. the commander delivery system components are intended for use via transfemoral, subclavian/axillary access routes. the edwards sapien 3 transcatheter heart valve system is indicated for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic stenosis who are judged by a heart team, including a cardiac surgeon, to be appropriate for the transcatheter heart valve replacement therapy. the edwards sapien 3 and sapien 3 ultra transcatheter heart valve system is indicated for patients with symptomatic heart disease due to failing (stenosed, insufficient, or combined) of a surgical or transcatheter bioprosthetic aortic valve or surgical bioprosthetic mitral valve who are judged by a heart team, including a cardiac surgeon, to be at high or greater risk for open surgical therapy (i.e., predicted risk of surgical mortality ? 8% at 30 days, based on the society of thoracic surgeons (sts) risk score and other clinical co-morbidities unmeasured by the sts risk calculator). the edwards sapien 3 transcatheter heart valve (thv) system with edwards commander delivery system is indicated for use in the management of pediatric and adult patients who have a clinical indication for intervention on a dysfunctional right ventricular outflow tract (rvot) conduit or surgical bioprosthetic valve in the pulmonic position with ? moderate regurgitation and/or a mean rvot gradient of ? 35 mmhg